Xenopus
Introduction
Otx genes are a class of vertebrate paired-like K 50 homeobox genes (Galliot et al., 1999) related to the orthodenticle gene of Drosophila melanogaster, which plays a crucial role in the development of the fly nervous system and sensory structures (Cohen and Jurgens, 1990; Finkelstein et al., 1990) . Similarly, Otx genes are essential for anterior central nervous system (CNS) and sensory organ formation (Acampora et al., 1995 (Acampora et al., , 1996 Acampora and Simeone, 1999; Freund et al., 1997; Furukawa et al., 1997; Martinez-Morales et al., 2001 ). In the frog, Xenopus laevis, at least three members of the Otx class have been isolated: otx1, otx2, and otx5 (crx) (Blitz and Cho, 1995; Kablar et al., 1996; Kuroda et al., 2000; Pannese et al., 1995; Vignali et al., 2000) .
During early phases of Xenopus embryogenesis, otx genes are expressed in the developing head tissues (rostral CNS: forebrain and midbrain; anterior endomesoderm of the head organizer) that do not undergo convergent extension movements. Misexpression of these genes by mRNA microinjection 0925-4773/$ -see front matter Ó 2013 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2013.09.002 leads to the development of anteriorized embryos with gastrulation defects (Andreazzoli et al., 1997; Blitz and Cho, 1995; Pannese et al., 1995; Vignali et al., 2000) . otx2 prevents cells from performing convergent extension movements through the transcriptional activation of Xenopus calponin homologue cnn1 (formerly XclpH3); calponin impairs movement generation by binding actin and myosin filaments (Morgan et al., 1999) . During successive phases of Xenopus development the expression patterns of the three otx genes diverge. In particular, otx2 and otx5 become strongly expressed in the presumptive cement gland (CG) territory, while otx1 is detected in this region only at a much lower level (Blitz and Cho, 1995; Kablar et al., 1996; Pannese et al., 1995; Vignali et al., 2000) . Consistent with this, the microinjection of otx2 and otx5, but not of otx1, mRNA leads to the formation of ectopic CGs in the embryo (Andreazzoli et al., 1997; Blitz and Cho 1995; Pannese et al., 1995; Vignali et al., 2000) . Therefore, during frog development, these three genes exploit both shared functions (ability to inhibit convergent extension), and differential actions (CG promoting activity). otx2 is able to promote CG formation in naïve ectoderm Sive, 1997, 2001; Sive and Bradley, 1996) where it directly or indirectly activates the CG markers ag1 (formerly Xag) and muc2 (formerly Xcg), respectively. Sive and coworkers also showed that the 129 C-terminal aa residues of Otx2 are required for this activity, therefore mapping the cement gland promoting region downstream of the WSP domain (Gammill and Sive, 2001 ). Similar to otx2, otx5 misexpression leads to ectopic CG formation; because of otx5 strong expression in the cement gland anlage, this suggests that otx5 plays a similar role to that of otx2, while otx1 is not able to activate CG formation. However, otx2 and otx5 show also divergent functions. In fact, their misexpression in the frog retina has different effects, with otx2 promoting bipolar cell fate and otx5 promoting photoreceptor cell fate (Viczian et al., 2003) . In the retinal context, the different cell fate specification abilities of the two proteins are due to a small divergent region just C-terminal to the homeodomain, that works as a retinal specificity box (RS box) (Fig. 1) ; when the sequence of the Otx5 RS box is changed into that of Otx2, mutant Otx5 switches its retinal activity to that of Otx2, and vice versa (Onorati et al., 2007) . These results altogether suggest that different molecular domains are responsible for the different activities of Otx proteins in the diverse cellular contexts. A very peculiar difference between Otx1 and Otx2 was observed in the development of the mouse inner ear. In gene replacement experiments, Otx2 is not able to rescue the loss of the lateral semicircular canal in Otx1 mutant mice, suggesting that the OTX1 protein has some properties that are not shared by OTX2 (Morsli et al., 1999) . Otx1 genes form an orthology group distinct from other Otx/Crx; OTX1 proteins share one serine-rich (Ser-rich) and one histidine-rich (Hisrich) domain that may account for their specific properties. The functional significance of the histidine stretch of OTX1 has been explored only in part (Bellipanni et al., 2010) , and it is not clear whether it could mediate its different action compared to other OTX family members. It is therefore important to characterize the parts of these proteins that are relevant for their distinct biological activities.
In the present work we have performed a molecular dissection of the Otx5 CG promoting ability in Xenopus; we compared the effect of misexpressing otx5 and otx1, as well as several mutant and deletion constructs, for their ability to trigger adhesive organ formation. The facility to score the CG morphologically, as well as the availability of CG molecular markers, makes the misexpression of otx mRNA a fast and convenient assay to monitor the diverse activities of our otx constructs. We thus identified the region of Otx5 that confers to this protein this specific ability, confirming a modular structure for Otx proteins. In addition, we show that the two specific Ser-and His-rich domains present in Otx1 protein suppress its potential to promote CG development.
Results

2.1.
The different activities of Xenopus Otx5 and Otx1 in promoting CG formation are due to differences in the C-terminal part Previous functional analyses have shown that both otx5 and otx2 are able to induce adhesive organ formation, while otx1 is not (Andreazzoli et al., 1997; Blitz and Cho, 1995; Bradley et al., 1996; Gammill and Sive, 1997 Kuroda et al., 2000; Pannese et al., 1995; Vignali et al., 2000) . Xenopus Otx1, Otx2 and Otx5 protein alignment by ClustalW software (http://www.ebi.ac.uk/Tools/msa/clustalw2) shows that the main differences in the primary sequence between these three homeoproteins are a Ser-rich region (aa 139-173) and a His-rich region (aa 249-289), present in Otx1 but absent in Otx2 and Otx5 (Fig. 1) . This suggested that the different action of Xenopus Otx2 and Otx5 compared to Otx1 in CG promoting activity might be due to these differences. Because Otx2 and Otx5 are very similar (76% identity overall) and have identical effects in misexpression experiments, we focused our research on Otx1 and Otx5. Since the main differences between them reside in the part C-terminal to the homeodomain (aa 98-290 for Otx5 and aa 98-338 for Otx1), we first swapped this region between Otx1 and Otx5, and used the two chimeric plasmids Xotx1N5C (encoding chimeric Otx1/Otx5) and Xotx5N1C (encoding chimeric Otx5/Otx1) in microinjection experiments (see Fig. 2 
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Xotx5-87ΔC Fig. 2 -Schematics of the constructs used in this study. Light grey: Xotx1 constructs; dark grey: Xotx5 constructs. RS: retinal specificity box; Ser-rich: serine-rich region; His-rich: histidine-rich region; D1: CGPD1; D2: CGPD2. schemes). We microinjected the corresponding mRNAs, and otx1 and otx5 mRNAs as controls, and checked for ectopic CG formation by whole mount in situ hybridization (WISH), using ag1 as a cement gland marker. Ventral injection of 800 pg otx5 mRNA is able to induce CG formation in about 80% of embryos; otx5 retains this activity when injected at progressively lower doses (with correspondingly lower frequencies of ectopic CG) ( Fig. 3A ; Table 1 ). On the contrary, injection of 800 pg otx1 mRNA does not induce ectopic adhesive organ development; ectopic CG formation was not observed even if otx1 mRNA was injected at a higher dose (1.2 ng) ( Fig. 3A and Table 1 ). Interestingly, injection of 800 pg of Xotx1N5C mRNA is able to induce ectopic CG formation in about 80% of embryos and this capability is displayed even at lower doses, thus reproducing otx5 activity ( Fig. 3A and Table 1 ). On the contrary, the reciprocal construct, Xotx5N1C, does not induce ectopic adhesive organ formation, even at higher doses ( Fig. 3A and Table 1 ). We concluded that the Otx1 and Otx5 differential ability to promote CG formation is due to their C-terminal part downstream of the homeodomain. By performing WISH experiments on injected caps, using ag1 as a probe, and RT-PCR experiments on mRNA extracted from sibling caps, we fully confirmed the observations obtained on whole embryos: the ability to turn on the cement gland markers ag1 and muc2 depends on the protein C-terminus (Fig. 4,  Fig. 5A and Table 2 ).
2.2.
The His-rich region mainly, and the Ser-rich region to a much lower extent, impair the potential ability of Otx1 to promote CG formation To define if the differential action was due to the Ser-rich region, to the His-rich region or both, we compared the activity of three different otx1 constructs lacking either or both of these specific portions, in similar microinjection experiments. Xotx1DSer is not able to promote ectopic adhesive organ formation when injected ventrally either at 800 pg or at a higher dose (Fig. 3A and Table 1) ; on the contrary, injection of 800 pg of Xotx1DHis mRNA promotes ectopic CGs in about 45% of embryos, and this effect persists even at lower doses (with a decrease in frequency of ectopic CGs) ( Fig. 3A and Table 1 ). Xotx1DHisDSer injected embryos show ectopic ag1 expression in more than 50% of injected embryos ( Fig. 3A and Table 1 ). We conclude that Otx1 is not able to promote CG fate due to the His-rich amino acid stretch. The data obtained on whole embryos were confirmed in animal cap assays. By WISH analysis, a high percentage of Xotx1DHis and Xotx1DHisDSer injected caps showed ag1 expression (77.2% positive caps, n = 57; 85.5%, n = 55; respectively). Xotx1DSer injected caps also showed ag1 expression, though with a lower frequency: about 40% of caps (n = 59) displayed labeling and in most explants we found a dotted weak ag1 signal ( Fig. 4 and Table 2 ). RT-PCR analysis performed on sibling injected caps fully confirmed these results: Xotx1DHis and Xotx1DHisDSer promote ag1 expression (though at a lower level compared to full length Xotx5 or Xotx1N5C constructs), while a weaker ag1 expression is detectable in Xotx1DSer injected explants; similar results were obtained with another cement gland marker, muc2 (Fig. 5A ).
These data suggest that the His-rich region mainly, and the Ser-rich region to a much lower extent, impair the potential ability of Otx1 to promote CG formation.
2.3.
The Otx5 C-terminus contains a bipartite CG promoting domain (CGPD)
The above described experiments, however, did not identify within the C-terminal of Otx5 the precise region actively involved in this ability. To localize this, we microinjected Xenopus embryos with mRNA from three different Xotx5 deletion constructs (see Fig. 2 for schemes; and Experimental Fig. 4 -Results of ag1 in situ hybridization on animal caps injected with the different constructs. Animal caps were dissected from embryos injected with 800 pg capped mRNAs as shown and ag1 expression was detected by in situ hybridization. GFP was used as microinjection tracer; microinjection of GFP alone was used as negative control. Procedures) and analyzed ag1 expression by WISH. We found that Xotx5-255DC has the same efficiency of full length Xotx5 in inducing CG formation: 80% of ventrally injected embryos showed ag1 ectopic expression ( Fig. 3A and Table 1 ). On the other hand, Xotx5-210DC, though able to induce ag1 ectopic expression, is much less efficient compared to full length Xotx5: only 25% of embryos showed ectopic CGs. Finally Xotx5-177DC is not able to induce CG formation in whole embryos (Fig 3A and Table 1 ). WISH performed on animal caps injected with the same Xotx5 deletion constructs fully confirm our data: Xotx5-255DC injected animal caps show a strong ag1 expression in more than 90% explants (n = 23), with an efficiency comparable with that of full length Xotx5 (96% positive caps, n = 88); Xotx5-210DC induces marker expression less efficiently (70% of ag1 positive animal caps; n = 29); finally, Xotx5-177DC does not promote ag1 transcription in any of injected animal caps (n = 35) ( Fig. 4 and Table 2 ).
RT-PCR analyses performed on sibling injected caps confirm our findings: the level of ag1 expression in Xotx5-255DC injected caps is comparable to that of Xotx5 injected explants; Xotx5-210DC induces a lower ag1 expression; in Xotx5-177DC injected caps, ag1 gene is very weakly turned on. As a further confirmation, the expression levels of muc2 almost completely resemble those of ag1 (Fig. 5B ).
These data suggest that the C-terminal region corresponding to aa 177-255 of Otx5 contains the crucial part actively responsible for eliciting CG formation and could therefore function as a CG promoting domain (CGPD). Otx5 CGPD is bipartite: CGPD1 (aa 210-255) is the most effective domain, while CGPD2 (aa 177-209) has a lower activity.
We therefore prepared ''minimal'' constructs containing the N-terminal part and the homeodomain of Otx1 (aa 1-97) fused to either CGPD1 or CGPD2 of Otx5, or both (Xotx1D1, Xotx1D2, Xotx1D2D1 constructs respectively; see Suppl. Fig. 1A ) and tested their mRNAs for their ability to promote ectopic CG formation. None of the three constructs elicited ectopic CG formation either in whole embryos or in animal cap explants (Suppl. Fig. 1B , and C and Suppl. Table 1 ).
2.4.
The Otx1 His-rich region acts as an active repressor on the Otx CG promoting ability
In Otx1 the sequence of the region corresponding to the CGPD1 is disrupted by the His stretch (Fig. 1) ; it is possible that this stretch simply impairs the ability of the cement gland promoting region; besides, it is possible that the His-rich region plays an active repressive role of CG promoting ability. To verify if the Otx1 His-rich region is able to inhibit Otx5 CG inducing activity, we inserted it downstream of the shortest Xotx5 construct (Xotx5-255DC) that is able to promote CG development with the same efficiency of full length Xotx5, and then tested the activity of the resulting Xotx5-255DC-His-rich construct (see Fig. 2 ). The ventral microinjection of this mRNA at the 800 pg dose does not lead to the formation of any ectopic adhesive structure on embryos ( Fig. 3A and Table 1). In injected animal caps we found only a very weak ag1 expression by WISH (Fig 4 and Tab. 2); by RT-PCR analysis we observed a weaker level of ag1 and muc2 transcripts compared to Xotx5 and Xotx5-255DC injected caps (Fig. 5B ). These data show that the His-rich region acts a repressor on Otx CG promoting ability.
2.5.
The Otx5 RS box is not required for the cement gland promoting ability
Because we previously showed that a RS box mediates the specific and diverse abilities of Xenopus Otx2 and Otx5 in the retina (Onorati et al., 2007) , we asked whether it is required for the CG promoting ability. We therefore tested Xotx5DRSbox mRNA in similar assays for induction of CG markers. We found that Xotx5DRSbox was able to induce ectopic CG marker expression in 43% of dorsally injected embryos (n = 144) at the dose of 800 pg, similar to full length Xotx5 (38.5%, n = 135); data on whole embryos were confirmed by animal cap assays ( Fig. 3B; Fig. 4 and Fig. 5C ; Table 2 ).
2.6.
The ability to promote CG formation is maintained upon dorsal injection All the described constructs have also been injected dorsally: the ability/inability to promote CG formation is maintained upon dorsal injection ( Fig. 3B; Suppl. Fig. 1B) , though in this case we generally observed a slightly lower frequency and muc2 expression was detected by RT-PCR on extracted mRNA. odc was used as internal reference. GFP is used as injection tracer; caps injected with GFP alone were used as a negative control.
in ectopic ag1 induction compared to ventral injections (data not shown).
Functionality and stability of chimeric and deleted proteins
To verify if reduction of the CG promoting function was due to a specific impairment of this activity rather than to a general reduction of the protein functionality, we tested the biological activity of our constructs by monitoring their ability to inhibit convergent extension, a typical effect of dorsal microinjection of otx mRNA. otx5 convergent extension phenotype decreases when all residues C-terminal to aa 177 are removed, and disappears completely only if we disrupt the homeodomain by removing aa 87-290 (construct Xotx5-87DC) (Fig. 3B, Table 3 ); this may be due to destabilization of the deleted Otx5-87DC protein (see below). otx1 is less effective than otx5 in inducing this phenotype, but its action increases if we remove the His-rich region (Fig. 3B and Table 3 ). Therefore, this lower effect of otx1 compared to otx5 may be due, at least in part, to the His-rich region. The minimal constructs are not able to affect convergent extension movements (Suppl. Fig. 1B and Suppl. Table 2) .
We finally monitored if the lower efficiency of some of our constructs in promoting ectopic CG formation and in affecting convergent extension movement was due to lower stability of the translated proteins. For this, we microinjected mRNAs coding for Myc-tagged forms of our proteins and checked for their presence at stage 20. Most of these mRNAs were translated into proteins that were detected at stage 20, including the Xotx5-177DC, Xotx5-255DC-His-rich, Xotx1, Xotx1DSer, Xotx1D1 that do not produce ectopic CG; on the contrary, Xotx5-87DC, Xotx1D2; Xotx1D2D1 were not translated into stable proteins (Suppl. Fig. 2A,B,C) .
Discussion
Otx proteins are key regulators of anterior vertebrate development that display shared as well as divergent functions (see Section 1). The molecular aspects of their respective Amount of injected mRNA is indicated in picograms. Percentage of positive animal caps is indicated in brackets. Additional comments in square brackets. GFP has been used as a tracer; GFP alone has been used as negative control. n: number of embryos. developmental abilities are not completely understood, but for Otx1 may reside in the Ser-rich and His-rich regions peculiar to this factor. We have performed a molecular dissection analysis of the Otx1 and Otx5 proteins in order to identify the molecular domains involved in their inability/ability to promote CG formation. We reasoned that this simple assay might shed some light onto the functional organization of these factors and clarify the specific properties of Otx1 compared to other Otx. A first set of injections with swapped constructs where the C-terminal parts of Otx1 and Otx5 were exchanged, clearly showed that the CG promoting activity relies on the C-terminal part. To map the functional domains of Otx5 required for CG induction, we prepared a series of C-terminal deletion constructs. Injections of their mRNAs showed that the region spanning aa 210-255 contains the most active CG promoting domain (CGPD1, that is largely overlapping with the His-rich region of Otx1); its removal causes a strong reduction of CG frequency in injected embryos, as well as a consistent decrease of CG marker expression in animal cap assays. Another region (CGPD2, aa 177-209) is also involved in CG induction: its removal causes a further decrease of ag1 and muc2 expression in animal cap explants, and the almost complete disappearance of ectopic CG on whole embryos.
While CGPD1 and CGPD2 are therefore required for the CG promoting ability of Otx5 in Xenopus, it may be questioned whether they are sufficient when they are tested in a minimal construct, where only the N-terminal part and homeodomain are included. Our results show that in this context, CGPD1 and CGPD2 are not sufficient, either alone or together, to trigger CG formation: either the resulting protein is unstable (constructs Xotx1D2, Xotx1D2D1) or, even if stable, it is not however able to induce ectopic CGs or CG markers (construct Xotx1D1). It is possible that the sequence created by recombining the homeodomain and CGPD2 renders the protein amenable to some proteolytic cleavage, therefore destabilizing it. However, a ''linker'' region between the homeodomain and CGPD may be required beyond a mere stabilizing effect of the protein. In Otx proteins, the region directly downstream of the homeodomain harbours the basic domain and the WSP domain, known to be important for their function (Chen et al., 2002; Gammill and Sive, 2001) . How much of this region can be dispensable for Otx driven CG formation is not completely clear; our study shows that the region identified as RS box in Otx2 and Otx5 can be removed from Otx5 without affecting its CG promoting activity, and we presume, though we did not prove directly, that it is not playing any role in Otx1 or Otx2. On the other hand, Gammill and Sive (2001) removed aa residues 95-159 from Otx2 and still observed CG marker induction in animal caps; since they removed both basic and WSP domains, as well as the RS box, this may suggest that a small region between the homeodomain and the CGPD is enough to provide a linker that would allow the protein to exploit its CG promoting activity.
Our results showed that in Otx1 the His-rich region exerts the major inhibitory function on CG inducing capability: when this region is removed, the Xotx1DHis construct becomes able both to induce ectopic CG development in whole embryos and to elicit expression of CG markers in animal cap assays. However, results in whole embryos and in animal caps show clearly that Xotx1DHis is not as efficient as Xotx5, which induces a higher frequency of ectopic CGs and a higher activation of ag1 and muc2 in animal caps. This is due to the fact that the His-rich region of Otx1 is partly overlapping with Otx5 CGPD1 (Fig. 1) : when the His-rich region is deleted, we do not actually ''restore'' the Otx5 CGPD1 sequence, because at the same time we are deleting non-His residues that are conserved between the two proteins. It is possible that they play a crucial role in CG promoting action; for example, they could be important for the proper folding and tertiary structure of the protein and their deletion could disrupt the structure and the optimal interactive properties of the protein. In addition, the Otx1 Ser-rich region may exert a similar, though weaker, inhibitory function on this potential Otx1 activity: in fact, Xotx1DSer weakly activates ag1 expression in the animal cap assay, though it remains unable to activate muc2 or to promote the formation of ectopic CG in whole embryos. Again, also Xotx1DHisDSer, like Xotx1DHis, does not have the full activity of Xotx5, suggesting once more that coextensive deletion of non-His residues in Xotx1DHisDSer may partly compromise the CGPD1 activity.
It may be interesting that the His-rich region can perform its action also from a different position within the protein. This indicates that Otx1 His-rich region acts as a domain actively repressing the potential of Otx proteins to promote CG, rather than being a mere disruptor of the CGPD1; in fact, while Xotx5-255DC, harbouring both CGPD1 and CGPD2, works as efficiently as Xotx5, the Xotx5-255DC-His-rich construct is completely unable to promote ectopic CG in whole embryos, and only weakly induces CG markers in animal caps. It may be possible that the His-rich region acts by masking the Otx5 CGPD, for example preventing recruitment of cofactors involved in CG promoting activity; or it may change the interactive properties of Otx so to allow recruitment of cofactors that suppress the CG promoting ability. Evidence that the interaction with cofactors deeply influence the developmental activity of homeodomain proteins has been gained for the fly Hox transcription factors; even common cofactors are able to differentiate the DNA binding specificity of Hox proteins (Slattery et al., 2011) .
These data on the whole suggest that the His-rich region, and perhaps the Ser-rich region (though in a much weaker manner), inhibit the potential ability of Otx1 to promote CG formation, and give a molecular explanation of the diverse activities of otx1 and otx5 in this respect. otx1 and otx5 also share a similar effect on convergent extension movements. It is interesting to note that removal of CGPD1 from Otx5 (construct Xotx5-210DC) leads to a substantial reduction of the CG promoting activity, while convergent extension is still inhibited as efficienciently as with full length Otx5; on the other hand the removal of CGPD2 (construct Xotx5-177DC) almost completely eliminates the CG promoting activity, while convergent extension effects are still observed (though at a reduced rate) and disappear only when the whole C-terminal is deleted from inside the homeodomain ( Fig. 3A and B ; Tables  1 and 3 ). This suggests that Otx5 CGPD1 is more specifically involved in mediating the effects on CG and not on convergent extension, while CGPD2 may be also relevant for inhibition of convergent extension. This observation is consistent with the fact that at the level of CGPD2 Otx1 and Otx5 show a high level of similarity. Generally Otx1 is less effective than Otx5 in impairing convergent extension, but its activity increases after the removal of the His-rich region; therefore, the insertion of the His stretch may also impair this aspect of Otx1 function.
Our data regarding Otx5 CG promoting domains are quite coherent with those obtained by Gammill and Sive (2001) for Otx2, which similarly promotes CG development, and suggest a close functional relationship between the two proteins in this respect. These authors showed that ag1 induction by Otx2 is reduced after the removal of its 81 Cterminal residues, almost corresponding to our CGPD1 plus the Otx tail; besides, they demonstrated that ag1 is not induced at all after the removal of the 129 C-terminal Otx2 residues, a region comprising our CGPD1, CGPD2 plus an additional N-terminal portion. The main difference between our results and those of Gammill and Sive (2001) is that the removal of the Otx tail from Otx5 does not cause a diminution of their activation ability on ag1 and muc2, as they observed after removing the Otx2 tail. This difference may be due to the fact that the Otx2 deletion construct (removing aa 241-288 of Otx2) used in their study also removes the region corresponding to the final part of CGPD1 of Otx5 (see Fig. 1 ).
Our data are also consistent with the mapping of the functional domains that in human CRX are involved in transactivating the opsin (rhodopsin) promoter: though we cannot establish a precise correspondence with the CRX activation domains AD1 and AD2 described by Chen et al. (2002) , the Otx5 CGP domain (D1 + D2) is comprised within AD1 and AD2; moreover, a molecular dissection of Otx5 carried out in our lab using a two-hybrid system (our unpublished data) has shown that Otx5 residues 174-290, spanning the whole CGP (D1 + D2), function as a transactivation domain; thus, our transactivation domain almost corresponds to AD1, the functionally most relevant region of CRX. Minor differences may be due to the diverse experimental approaches and to the different promoters/genes monitored in the two studies.
These data on the whole suggest that Otx5 CGPD can work as a functional domain involved in modulating the gene set leading to CG formation; the insertion of the His-rich region within this domain may modify its regulative properties toward this gene set.
Our results clearly show that the Otx1 specific His-rich region exerts a crucial function in differentiating Otx actions. The comparison of Otx-related proteins from different species suggests the importance of the His-rich region during evolution. Histidine stretches, in almost the same position, are present in all Otx1 proteins and are considered a distinctive character of this orthology group, being absent in other Otx proteins of Gnathostomes and in Otx of all other organisms (Germot et al., 2001) . It is very likely that these peculiar regions of Otx1 appeared, for instance as insertions, in an Otx1 ancestral gene, that initially had functional characters similar to other Otx genes. It is interesting to note that the microinjection of Drosophila otd in Xenopus embryos leads to the formation of ectopic adhesive organs (Lunardi and Vignali, 2006) , suggesting that the ability to activate the genetic pathways that are involved in Xenopus CG formation is an ancestral property of Otx/Otd proteins, that was lost in Otx1 upon the appearance of the histidine stretch; also human OTX1 (Andreazzoli et al., 1997) does not induce CG, differently from human OTX2 (Pannese et al., 1995) . An interesting aspect of Otx1 function arises from experiments in mouse; in this organism Otx1 is involved in the development of the lateral semicircular canal of the inner ear, the absence of which is not rescued either by Otx2 or by otd (Acampora et al., 1996 (Acampora et al., , 1998 Morsli et al., 1999) . It may be possible that Otx2 inability to rescue Otx1À/À ear defects is due to the absence of the His-rich region. Given that the His-rich region is the most conserved divergent character between Otx1 and the other Otx proteins, these data taken together can suggest the hypothesis that the His-rich region is involved in modulating two different genetic pathways: the insertion of the His-rich region inhibits Otx1 capability to induce CG formation (by disrupting/repressing the CG promoting domains and silencing the downstream genes leading to CG formation) and, in a different cellular context, makes it able to activate the development of the inner ear semicircular canal. From this point of view the insertion of the His-rich region in Otx1 could be an interesting case where evolution of a new part of protein has led both to gain and loss of functions compared to the ancestral protein. However, we cannot exclude that the Ser-rich region may also play a novel evolutionary role in Otx1; even though our experiments may suggest for it a minor role, this may be due to the CG specific aspects investigated in our experimental system. Evolution of new functional properties by sequence divergence has been described for other homeodomain proteins. For example, appearance of a QAQA-poli alanine stretch has endowed insect Ubx with new functional properties compared to Ubx proteins of other arthropod lineages, turning Ubx to into a constitutive repressor of dll gene expression (Galant and Carroll, 2002; Ronshaugen et al., 2002) ; while this happened for Ubx along separate arthropod lineages, in our case functional divergence of Otx proteins happened in duplicate genes within the same lineage.
In conclusion, we have highlighted molecular domains of Otx1 and Otx5 proteins that explain some of their different activities in living Xenopus embryos. Interestingly, these domains are differently involved in mediating the convergent extension and CG promoting effects; moreover, they are physically separated from the RS box involved in retinal cell commitment (Onorati et al., 2007) . Our results also show that the RS box, as well as the Otx tail, is not involved at all in Otx5 CG inducing action. Therefore, Otx proteins have a modular structure with domains that can mediate different aspects of their activities in a rather independent way. It is possible that these domains modulate the activity of the Otx proteins by recruiting different cofactors, thereby modifying their DNA binding properties and ability to target specific gene sets. For example, Otx2 and Otx5 have different efficiencies to activate the opsin promoter that correlate with their differential interactive abilities with Nrl; these in turn depend on their specific RS box (Onorati et al., 2007) : therefore, the different interaction with Nrl (and possibly other cofactors) changes the ability of Otx proteins to target different retinal gene sets. Similarly, it is feasible that the His-rich and Ser-rich regions modify Otx1 to endow it with specific biochemical properties that account for its distinct biological activity.
4.
Experimental procedures 4.1.
DNA constructs
The main constructs used in the present study are shown in Fig. 2. pCS2Xotx5 wild-type construct was previously described in Vignali et al. (2000) and contains the Xotx5 coding sequence plus some flanking regions.
pCS2Xotx1 wild-type construct was generated as follow: Xotx1 5 0 UTR (88 nt) + coding region was amplified from Xenopus laevis embryos cDNA by using specific primers, with EcoRI restriction sites; PCR product was digested with EcoRI and inserted into EcoRI site of pCS2. pCS2Xotx1N5C and pCS2Xotx5N1C swap domain constructs were generated as follows: by site directed mutagenesis a silent mutation generating a KpnI/Asp718 site was produced in pCS2Xotx5 construct at level of the codon encoding aa 61, and at the equivalent position of pCS2Xotx1. These sites allowed precise swapping of the coding region C-terminal to aa 61, leaving unchanged the homeodomains encoded in the swapped proteins. Because the homeodomains are identical in the region between aa 61 and the polyQ stretch at the homeodomain end, swapping is only effective beyond aa 99 of both sequences (aa 99 to end).
pCS2Xotx1DSer deletion construct derives from pCS2Xotx1 by the deletion of the Ser-rich region spanning amino acids 139-173. This was obtained by PstI digestion, performed after insertion of two PstI restriction sites at Ser-rich region borders by site directed mutagenesis, and subsequent DNA re-circularization. Similarly, pCS2Xotx1DHis deletion construct derives from pCS2Xotx1 wild-type construct by insertion of two NcoI restriction sites at His-rich region borders by site directed mutagenesis and subsequent removal of the NcoI fragment spanning the His-rich region (aa 249-289). pCS2Xotx1DHisDSer carries both the His-and Ser-rich region deletions described above. In these three deletion constructs the rest of the encoded aminoacid sequence was left unchanged. pCS2Xotx5DRSbox was described by Onorati et al. (2007) and lacks the retinal specificity box (spanning aa 100-107).
pCS2Xotx5-177DC, pCS2Xotx5-210DC and pCS2Xotx5-255DC are deletion constructs lacking different Otx5 carboxy-terminal portions, obtained by the insertion of a stop codon at positions corresponding to aa 177, 210 and 255 respectively, by site directed mutagenesis.
pCS2Xotx5-255DC-His-rich codes for a fusion of Otx5-255DC and Otx1 His-rich region. The otx1 His-rich encoding region (aa 249-289) was PCR amplified from pCS2Xotx1 wild-type construct using specific primers with BcuI restriction sites and cloned into a BcuI site created (without effect on aa sequence) at position corresponding to aa 255 of pCS2Xotx5 construct. A stop codon was inserted downstream of the His-rich region.
pCS2Xotx5-87DC codes for a truncated form of Otx5, due to the changing of codon 87 for the homeodomain key residue K into a premature stop codon. pCS2Xotx1D1, pCS2Xotx1D2 and pCS2Xotx1D2D1 were generated as follows: a PstI site was created by site directed mutagenesis at the level of aa residue 96 of Otx1, at the end of the homeodomain (this changed a Q into an L); CGPD1, CGPD2 or CGPD2D1 encoding fragments were PCR amplified from otx5 and cloned into the PstI site; the L was turned back into the original Q by site directed mutagenesis; a stop codon was provided downstream of the inserted fragment.
We also generated Myc-tagged versions of several otx constructs by subcloning of the respective cDNAs into a pCS2-Myc vector.
All constructs were verified by sequencing.
Xenopus laevis embryos
Eggs were obtained from Xenopus laevis females injected with 800 IU of human gonadotropin; embryos were generated and grown as previously described by Newport and Kirschner (1982) and staged according to Nieuwkoop and Faber (1967) . All the experiments involving animals described in this article have been carried out in accordance with EU Directive 2010/63/EU.
4.3.
In situ hybridization
Embryos were processed for whole-mount in situ hybridization (WISH) as described by Harland (1991) ; for animal caps Proteinase K was omitted. Embryos and caps were bleached as described by Mayor et al. (1995) . ag1 probe was used for CG detection .
4.4.
RNAs methods, embryo microinjections and animal cap assays Capped RNAs were in vitro transcribed by SP6 RNA polymerase from NotI linearized pCS2 constructs described above, using the mMessage mMachine Kit (Ambion). Embryos were bilaterally injected in the animal region of dorsal or ventral blastomeres of 4-cell stage embryos in 0.1xMMR, 4% Ficoll. Embryos were grown overnight at 14°C and then transferred in 0.1 · MMR and cultured at 14°C until tailbud stage. For animal cap assays, RNAs were injected in the animal pole region of 1-cell stage embryos. Animal caps were dissected at stage 9 in 1 · MBS, let heal and then cultured in 1 · MBS until sibling embryos reached tailbud stage 25.
RT-PCR
Total RNAs were extracted from animal caps with the NucleoSpin RNAII kit (Macherey-Nagel) and in vitro reversetranscribed using the GoScript Reverse Transcription System (Promega) and oligodT primers; cDNA products were amplified by PCR using ag1 and muc2 specific primers (Gammill and Sive, 1997) . odc primers were used as internal control (Bouwmeester et al., 1996) . For all primers 24 cycles were used.
Protein extraction and Western blots
Embryos injected with mRNA for Myc-tagged version of otx constructs were processed at stage 20 for protein extraction.
Embryos were homogenized in JS solution (250 mM HEPES pH 7.5, 150 mM NaCl, 1%, glycerol, 1%, Triton X-100, 1.5 mM MgCl 2 , 5 mM EGTA; protein inhibitors were added just before use) by vortexing and subsequent shaking for 15 min at 4°C on a nutator; the solution was then centrifuged three times; the aqueous phase was transferred at each step, and finally protein concentration was determined by the Bradford method; protein dye was then added before denaturation at 95°C for 5 min. SDS-PAGE and Western blot detection of Myctagged proteins followed by standard procedures. We used anti-Myc and anti-a-tubulin SIGMA antibodies (M-5546 and T-6199 respectively) as primary antibodies, and antimouse IgG (Fab specific) peroxidase conjugate (SIGMA A-2304) as secondary antibody.
